LAM RESEARCH CORPORATION (LRCX) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2025-12-28

Swipe to see the full flow
LAM RESEARCH CORPORATION (LRCX) FY2026 Q2 Balance SheetBalance sheet as of 2025-12-28. The chart shows assets, liabilities and equity at that date.Current liabilities$6.21 BLiabilities$11.25 BNon-current liabilities$5.03 BEquity$10.15 BCurrent assets$14.02 BAssets$21.39 BGross equity(calculated)$40.45 BNon-current assets$7.37 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoriesAccounts receivable, less allowance of $7,717 as of December 28, 2025, and $6,496 as of June 29, 2025Prepaid expenses and other current assetsOther assetsProperty and equipment, netGoodwill and intangible assets, netAccrued expenses and other current liabilitiesDeferred profitTrade accounts payableCurrent portion of long-term debt and finance lease obligationsLong-term debt and finance lease obligationsIncome taxes payableOther long-term liabilitiesRetained earningsAdditional paid-in capitalCommon stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of December 28, 2025 and June 29, 2025; issued and outstanding, 1,251,180 shares as of December 28, 2025, and 1,268,740 shares as of June 29, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost; 1,705,662 shares as of December 28, 2025, and 1,687,582 shares as of June 29, 2025Accumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$6.21 BAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$2.27 BDeferred profitDeferred profit$2.16 BLiabilitiesLiabilities$11.25 BTrade accounts payableTrade accounts payable$1.03 BCurrent portion of long-term debt and finance lease obligationsCurrent portion of long-term debtand finance lease obligations$754.01 MNon-current liabilitiesNon-current liabilities$5.03 BLong-term debt and finance lease obligationsLong-term debt and finance lease obligations$3.73 BEquityEquity$10.15 BIncome taxes payableIncome taxes payable$667.64 MCurrent assetsCurrent assets$14.02 BAssetsAssets$21.39 BOther long-term liabilitiesOther long-term liabilities$635.21 MGross equity (calculated)Gross equity(calculated)$40.45 BCash and cash equivalentsCash and cash equivalents$6.18 BInventoriesInventories$4.04 BAccounts receivable, less allowance of $7,717 as of December 28, 2025, and $6,496 as of June 29, 2025Accounts receivable, net$3.49 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$307.91 MNon-current assetsNon-current assets$7.37 BRetained earningsRetained earnings$31.50 BOther assetsOther assets$2.80 BProperty and equipment, netProperty and equipment, net$2.71 BGoodwill and intangible assets, netGoodwill and intangible assets, net$1.86 BAdditional paid-in capitalAdditional paid-in capital$8.95 BCommon stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of December 28, 2025 and June 29, 2025; issued and outstanding, 1,251,180 shares as of December 28, 2025, and 1,268,740 shares as of June 29, 2025Common stock$1.25 MTreasury stock, at cost; 1,705,662 shares as of December 28, 2025, and 1,687,582 shares as of June 29, 2025Treasury stock−$30.20 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$98.70 M
Chart details

LAM RESEARCH CORPORATION (LRCX) FY2026 Q2 Balance Sheet

Balance sheet as of 2025-12-28. The chart shows assets, liabilities and equity at that date.

Assets
21,391,171,000 US dollars
Current assets
14,018,023,000 US dollars
Non-current assets
7,373,148,000 US dollars
Liabilities
11,245,745,000 US dollars
Current liabilities
6,213,153,000 US dollars
Non-current liabilities
5,032,592,000 US dollars
Equity
10,145,426,000 US dollars
Cash and cash equivalents
6,180,440,000 US dollars
Inventories
4,037,682,000 US dollars
Accounts receivable, less allowance of $7,717 as of December 28, 2025, and $6,496 as of June 29, 2025
3,491,987,000 US dollars
Prepaid expenses and other current assets
307,914,000 US dollars
Other assets
2,798,122,000 US dollars
Property and equipment, net
2,710,989,000 US dollars
Goodwill and intangible assets, net
1,864,037,000 US dollars
Accrued expenses and other current liabilities
2,267,488,000 US dollars
Deferred profit
2,164,722,000 US dollars
Trade accounts payable
1,026,937,000 US dollars
Current portion of long-term debt and finance lease obligations
754,006,000 US dollars
Long-term debt and finance lease obligations
3,729,742,000 US dollars
Income taxes payable
667,639,000 US dollars
Other long-term liabilities
635,211,000 US dollars
Retained earnings
31,498,233,000 US dollars
Additional paid-in capital
8,948,439,000 US dollars
Common stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of December 28, 2025 and June 29, 2025; issued and outstanding, 1,251,180 shares as of December 28, 2025, and 1,268,740 shares as of June 29, 2025
1,251,000 US dollars
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding
0 US dollars
Treasury stock, at cost; 1,705,662 shares as of December 28, 2025, and 1,687,582 shares as of June 29, 2025
negative 30,203,796,000 US dollars
Accumulated other comprehensive loss
negative 98,701,000 US dollars
Gross equity (calculated)
40,447,923,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
LAM RESEARCH CORPORATION (LRCX) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!